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A B S T R A C T
We have identified in the literature variants in 64 genes that may be involved in gene-obesity-behaviour interactions.
Personalisation of behaviourally based preventive approaches against obesity seems feasible, however obesity genomics is
still in the discovery phase of translational research and abundant replication studies are needed before these largely pio-
neering findings can be extended to practice and population impact. Automation of search algorithms and development
of more efficient tools for knowledge synthesis of genomic research into gene-obesity-behaviour interactions might facili-
tate the advent of widely available personalised prevention approaches. Our future efforts shall therefore concentrate on
developing such tools, as well as a research repository dedicated to the use of public health genomics for obesity control.
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Introduction
Efforts aimed at primary and secondary prevention of
cardiovascular disease, the major killer of contemporary
adult populations1–3, largely rely on modification of risk
behaviours related to smoking, physical activity, dietary
intake, and alcohol consumption4,5. Control of obesity
and hypertension, the interim risk states between health
and disease, constitute another large part of preventive
ventures.
In the public health that increasingly turns its atten-
tion toward genomics, the major challenge is to under-
stand the role of genetic variants in susceptibility to
chronic diseases and associated risk factors6. This has re-
quired characterising the nature of gene variation, assem-
bling an extensive catalogue of single nucleotide poly-
morphisms (single base-pair mutations that occur at a
specific site in the DNA sequence, SNPs) in candidate
genes, and performing association studies and other gene
mapping studies.
A step further, we need to incorporate findings from
genomics into clinical and public health interventions.
Beyond associations studied in classical epidemiology –
those of behavioural risk factors and obesity phenotype7
– as well as beyond the major genes that play a deciding
role in monogenic obesity, such as is leptin deficiency for
example, we were interested in SNPs – primary genetic
information and primary variants where the genetic pre-
disposition could be discovered – and their role in devel-
oping common obesity8. No single SNP will cause a com-
plex trait; however, in a gene-environment interaction, a
combination of variants exposed to what is often called
'obesogenic' environment will increase the relative risk
that an individual develops the trait.
The extent to which this process is mediated by asso-
ciations between particular SNPs and behavioural risk
factors for overweight or obesity may determine opportu-
nities for novel, personalised preventive interventions.
Currently most effective interventions combine nutri-
tion education and exercise counselling with behavioural
strategies to improve a person’s ability to lose weight9,10.
In other words, current interventions require that all
people work on both sides of the intake-expenditure en-
ergy equation. Such one-size-fits-all approach has not
reaped much success in controlling the burden of obesity.
Alternatively, personalised prevention strategies might
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be able to identify people who are more likely to benefit
from focusing on one or the other side of the energy
equation, as well as people who are more likely to lose
weight in response to certain macronutrient diet compo-
sitions (e.g., low-fat or low-carbohydrate diet).
Objectives
In the informational abundance of over 10 million hu-
man SNPs that are currently listed in publicly accessible
databases11, we aimed to identify SNPs that are linked
both with increased body weight and behavioural risk
factors for this trait, thus holding promise for future de-
sign of personalised behaviourally based preventive in-
terventions to reduce obesity.
Methods
In the initial search, the results of which have previ-
ously been communicated12, we searched the Cochrane
Database of Systematic Reviews, MEDLINE, INSPEC,
Current Contents, and Cochrane Controlled Trials Reg-
ister for abstracts of surveys published to December 2008
in any language, which had examined the associations
between any SNPs and behaviours implicated in the aeti-
ology of human obesity, namely physical activity, smok-
ing, diet, alcohol consumption, and psychological stress.
Two researchers checked all abstracts for eligibility and
we included in both the previous and the current report
only those articles that found significant associations be-
tween identified SNPs and one or more behaviours of in-
terest. Animal studies were excluded.
For this report, we expanded the search to December
2009 using HuGE Navigator, an integrated knowledge
base on human genome epidemiology13. HuGENavigator
is updated weekly from PubMed by means of an automa-
tic literature screening program. A genetic epidemiologist
selects abstracts that meet inclusion criteria and indexes
them by gene, category, and study type. We searched
HuGE Navigator’s Phenopedia for gene-environment in-
teraction articles with obesity and behaviours of interest
as search terms.
Results
Our initial search returned 77 abstracts of which 18
were deemed eligible for inclusion (Tables 1 and 2). The
HuGE Navigator search returned all but one abstracts
identified in the initial search14, as well as 45 additional
articles eligible for inclusion (Table 3). In total, gene-obe-
sity-behaviour interactions were reported for 46 genes.
In one article, where 26 SNPs on the fat mass and
obesity associated (FTO) gene were found to be associated
with body mass index (BMI), two variants – rs1477196
and rs1861868 – were only associated with obesity in
people with low levels of physical activity. No association
between these two variants and BMI was found among
people with above-average physical activity scores.
Another article indicated that alcohol consumption may
play a protective mediating role in one variant’s impact
on glucose metabolism: in men, carriers of 14672C>G in
the promoter region of hormone-sensitive lipase locus
(LIPE) who did not drink alcohol had higher glucose levels
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TABLE 1
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) (IDENTIFIED IN THE INITIAL SEARCH) WHICH SEEM TO BE INVOLVED IN
THE PATHOPHYSIOLOGY OF OBESITY AND LINKED WITH RISK BEHAVIOURS (PHYSICAL ACTIVITY, ALCOHOL CONSUMPTION, AND
CONTROL OF APPETITE)
People SNP Phenotype associations
704 healthy Old order Amish people [Arch
Intern Med 168 (2008), 1791–7]
rs1477196 and rs1861868 on fat mass and
obesity associated (FTO) gene
Associated with body mass index in people
with low physical activity scores (adjusted
for age and sex)
Population of mostly overweight and
obese 373 men and 361 woman [Clin
Genet 65 (2004), 93–100]
14672C>G in promoter region of
hormone-sensitive lipase locus (LIPE)
gene
In women, LIPE 14672G was associated
with significantly higher total cholesterol,
LDL-cholesterol and apoE; in men,
carriers who don’t drink alcohol have
higher glucose levels than non-carriers
1,058 cases and 1,102 controls [Cancer
Epidemiol Biomarkers Prev 15 (2006),
811–5]
Ser(326)Cys and 11657A/G in
Oxodeoxyguanosine (OGG1) gene
Ser(326)Cys associated with breast cancer
risk among moderate alcohol drinkers
11657A/G associated with BMI>25
First: 93 cases 469 controls; Second: 564
cases 562 controls; Third: 394 cases 958
controls [Human Molecular Genetics 16
(2007), 3017–26]
rs2293855 in myotublarin-related protein
9 (MTMR9) gene
MTMR9 mRNA levels increased after
fasting and decreased after high-fat diet –
regulation of hypothalamic neuropeptides
and thus possibly control of appetite
Sample of 218 obese Finnish sibling pairs;
independent samples of 837 cases and 968
controls [J Clin Invest 112 (2003), 1762–72]
SNP haplotype of the SLC6A14 gene
Evidence of linkage emerged mainly from the
obese male sib pairs, suggesting a gender-
specific effect for the underlying gene
2455 white female twins [Obesity (Silver
Spring) 15 (2007), 5–9]
A tagging SNP/tSNP, Ala484Thr
(rs7498665) in the region encompassing
the human SH2-B gene
Ala484Thr (minor allele frequency 0.38)
was associated with serum leptin, total
fat, waist circumference, and body weight
than non-carriers, but there were no differences among
people who do drink alcohol. In the oxodeoxyguanosine
(OGG1) gene, variant Ser(326)Cys was found to be asso-
ciated with the risk for breast cancer, but only among
moderate alcohol drinkers, while another variant in the
same gene – 11657A/G – was associated with increased
body weight.
Variants in the myotublarin-related protein 9 (MTMR9)
gene, SLC6A14 gene, and SH2-B gene showed the poten-
tial to affect control of appetite.
A number of articles implicated various SNPs, located
on several genes, in changing carriers’ response to diet.
In the TUB gene, for example, AG heterozygote and AA
homozygote of the rs2272382 derived less energy from
fat, and both were associated with increased energy intake
from carbohydrates. Both rs22728133 and rs1528133
were also associated with higher glycaemic load in the
diet, which was higher than glycaemic load among the
wild types. Concerning the APO gene, among people with
APOA5-1131T (major allele) the BMI increased with
higher fat intake; however, in APOA5-1131C (minor al-
lele) no increase was seen in BMI with increased fat con-
sumption. Carriers of APOA5-1131C minor allele had a
lower risk for overweight and obesity, but not when fat
intake was low.
UCP-3 was exposed as an anti-thrifty gene that dissi-
pates energy as heat and prevents obesity, while variants
in the adiponectin gene had an impact on insulin resis-
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TABLE 2
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) (IDENTIFIED IN THE INITIAL SEARCH) WHICH SEEM TO BE INVOLVED IN THE
PATHOPHYSIOLOGY OF OBESITY AND LINKED WITH RISK BEHAVIOURS (DIET)
People SNP Phenotype associations
1680 middle-aged Dutch women [Plos
ONE 3 (2008), e1405]
rs2272382, rs227283, and rs1528133
in the TUB gene
Eating behaviour associated with body
composition and macronutrient intake
451 obese participants [Horm Metab Res
39 (2007), 395–7]
P129T polymorphism in fatty acid
amide hydrolase (member of the
endocannabinoid (ECS) system)
After six weeks of low fat diet, carriers had a
significantly greater decrease in total cholesterol
and triglycerides, compared with wild type
1,073 men and 1,207 women in the
Framingham offspring study [J Mol Med
82 (2007), 119–28]
APOA5-1131T>C polymorphism
Modulates the effect of fat intake on BMI and
risk for overweight or obesity
214 overweight women from Korea
[Metabolism 55 (2006), 578–86]
Haplotype 1 (ht1) (CGTACC) on the
uncoupling protein 3 (UCP-3) gene
After one month of low-energy diet, associated
with greater reduction in body weight, BMI,
body fat mass; but not with body fat free mass
453 overweight women from Korea
[Biochem Biophys Res Commun 335
(2005), 624–30]
A-3826G, A-1766G, and Ala64Thr
(G+1068A) on UCP-1 gene
After one month of very low calorie diet,
ht3[GAG] associated with faster reduction in
waist-to-hip ratio and body fat mass
249 non-diabetic overweight or obese
people from Korea [Int J Obes (Lond) 30
(2006), 1702–8]
276G>T at adiponectin (ADIPOQ)
gene
Modifies response to low calorie diet
300 patients randomised to two diet
groups over 3 to 12 months [Proc Nutr
Soc 61 (2002), 427–34]
Various SNPs on several genes
Interactions with metabolic response to
Mediterranean/low fat diet or Western type diet
30 men and 29 women [J Nutr 138
(2008), 1609–14]
–11377 C>G at the adiponectin gene
C/C homozygous men had a greater decrease in
the steady-state plasma glucose concentrations
when changing from SFA-rich to MUFA-rich diet
458 overweight women [Biochem
Biophys Res Commun 359 (2007),
451–6]
10 polymorphisms in uncoupling
protein UCP-2 and UCP-3
Modified response to a one-month very-low
calorie diet regimen
651 people of Japanese ethnicity (274
Hawaiian Americans and 377 native
Japanese people) [Obesity (Silver
Spring) 16 (2008), 1463–6]
rs235326 in the gene encoding human
integrin beta 2 subunit (ITGB2)
In Hawaiian Americans (whose diet has become
»westernized«): compared with C carriers, TT
homozygotes were 3.29-times more likely to be
obese; no such association was found among
people living in Japan
1,357 obese adults and children from
France [Obes Res 11 (2003), 1163–7]
79-bp T-to-C on the 3’ region of the
diacylglycerol acyltransferase (DGAT)
encoding gene
Not associated with obesity-related phenotypes
in this study, although a positive association has
been reported in Turkish women
People living in affluent societies in
several parts of Asia and Pacific islands
[Biochem Biophys Res Commun 295
(2002), 207–22]
Thrifty SNPs encoding FABP”, MTP,
CAL10, beta 3AR, apo-E, UCP2,
UCP3-p, PPARgama2 and LEPR
Differences in these SNPs between Mongoloids
and Caucasoids may have been caused by
natural selection depending on the types of
agricultures practiced in different regions and
consequently diet
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TABLE 3
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) (IDENTIFIED IN THE HUGENAVIGATOR SEARCH) WHICH SEEM TO BE INVOLVED IN
THE PATHOPHYSIOLOGY OF OBESITY AND LINKED WITH RISK BEHAVIOURS (PHYSICAL ACTIVITY, DIET, AND MIXED INTERVENTIONS)
People SNP Phenotype associations
Physical activity
604 Caucasian individuals (aged 40–65
yr) [J Clin Endocrinol Metab 86 (2001)
5881–7]
Gly16Arg in the beta(2)
– adrenergic receptor
(BAR-2) gene
Women carriers of the Arg16Arg genotype had lower fasting
plasma NEFAs (nonesterified fatty acid) (P < 0.01) and greater
suppression of NEFAs (P < 0.01) after an oral glucose load
than women bearing the Gly16 allele. After adjustment for
confounding by age, smoking, and BMI, the effect of the
Arg16Arg genotype on the suppression of NEFA levels was
modified by physical activity level (P for interaction <0.05)
FTO variant rs1121980 was genotyped
in 20,374 participants (39–79 y of age)
from the EPIC and Nutrition-Norfolk
Study [Am J Clin Nutr 90 (2009)
425–8]
rs1121980 in the FTO
Physical activity attenuates the effect of the FTO rs1121980
genotype on BMI and WC
Two European prospective
population-based cohorts of 4,762
Finnish adolescents (NFBC 1986) and
3,167 French adults (D.E.S.I.R.) [J Mol
Med 87 (2009) 537–46]
rs1421085 and
rs17782313 in FTO and
MC4R
The combined effects of common polymorphisms in FTO and
MC4R are additive, predictive of obesity, and may be influenced
by interactions with physical activity levels and gender
862 subjects from the Quebec Family
Study [Hum Genomics 3 (2009)
157–68]
LIPE C-60G
polymorphism
In women, no evidence of a gene-physical activity interaction
was observed, except for subcutaneous abdominal fat (P = 0.05).
Between physical activity and body fat in men are dependent
on the LIPE C-60G
737 Korean children and 732 adults
[Obesity (Silver Spring) 17 (2009)
355–62]
(UCP)2 and UCP3;
UCP2-866G>A,UCP2Al
a55Val, and
UCP3-55C>T
UCP3-55CC carriers had higher BMI values than UCP3-55T
carriers. Low physical activity may aggravate the susceptibility
to overweight in UCP2-866GG and UCP3-55CC carriers
1306 participants enrolled in the
JingNing population study [J
Hypertens 26 (2008) 2161–7]
ADRA2B D/I
polymorphism
ADRA2B D allele is associated with a favourable
anthropometric and metabolic profile in Chinese population,
especially in physically less active participants
3,856 type 2 diabetic case subjects and
4,861 normal glucose-tolerant control
subjects [Diabetes 57 (2008) 95–101]
rs9939609 in the FTO
Low physical activity seems to accentuate the effect of FTO
rs9939609 on body fat accumulation
Sample of 14,716 African Americans
(AAs) and whites from the ARIC [Int J
Obes (Lond) 31 (2007) 919–26]
GNB3 825C>T in the
GNB3 gene
The variation within the GNB3 gene may interact with physical
activity level to influence obesity status
A population-based study comprising
899 women and 902 men aged between
30 and 75 years in Vara, Sweden
[Diabetologia 49 (2006) 496–500]
PPARGC1A GLy482Ser
The risk of obesity associated with 482Ser is evident only in
physically inactive elderly male subjects. Whenever possible, the
level of physical activity should be addressed in future studies
on disease risk associated with PPARGC1A Gly482Ser
157 obese subjects (BMI > or = 30)
and 150 controls (BMI < 25) [Ann
Nutr Metab 49 (2005) 183–8]
UCP3 –55C>T
polymorphism
UCP3 –55C>T polymorphism carriers have apparently a lower
risk of obesity when taking into consideration recreational
energy expenditure. Interestingly, this inverse beneficial
association may only occur in people with a high level of
physical activity
Diet
108 subjects who underwent an 8-day
modified medical fasting treatment
[Ann Nutr Metab 54 (2009) 184–8]
GNB3 C825T
polymorphism
Pronounced mental discomfort during fasting in 825T allele
carriers might partly explain their increased risk for obesity
180 Spanish volunteers (BMI:
31.4+/–3.2 kg/m (2) [Horm Metab Res
41 (2009) 55–61]
rs17300539 (11391 G/A)
in the adiponectin gene
A allele confers protection from weight regain after a
low-calorie diet, and the effect is particularly evident 32–60
weeks after the dietary intervention, when improvement in GG
subjects had disappeared
Detailed dietary report information on
FTO variation and dietary intake [Am
J Clin Nutr 88 (2008) 971–8]
rs9939609 in the FTO
Persons carrying minor variants at rs9939609 were consuming
more fat and total energy than were those not carrying such
variants
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Cohort of 1,721 Caucasian men and
women with a BMI of 25kg/m(2) or
more [Mol Genet Metab 95 (2008)
188–91]
CB1, NPY, 420C>G
polymorphisms in the
resistin gene
Genetic polymorphisms associated with obesity may become
relevant only under the condition of a low calorie diet
Population-based sample of
Caribbean-origin Hispanics (n = 920,
aged 45–74 y) [Nutr 138 (2008) 1852–8]
rs894160 (11482G>A)
in the PLIN gene
In subjects with higher complex carbohydrate intake, the minor
allele was protective against obesity, whereas in subjects with
lower carbohydrate intake, the minor allele was associated with
increased obesity
204 obese people [Diabetes Res Clin
Pract 82 (2008) 113–8]
FABP2
Weight loss is associated with different changes, depending on
the FABP genotype with both hypocaloric diets tested
78 obese people [Ann Nutr Metab 52
(2008) 209–14]
Lys656Asn
polymorphism in the
LEPR gene
In wild type patients, the changes in serum leptin
concentration due to 2 months’ intervention with low fat are
higher than with a low carbohydrate diet
107 obese people (body mass index
>30) [Horm Metab Res 40 (2008)
214–8]
–55CT polymorphism of
the UCP3 gene
Patients with –55CC genotype have a significant decrease in
leptin, interleukin 6, BMI, weight, fat mass, systolic blood
pressure, LDL cholesterol, waist circumference, waist-to-hip
ratio weight, fat mass, and systolic blood pressure, in response
to a hypocaloric diet
29 obese and 45 non-obese people
18–40 years old [Behav Neurosci 121
(2007) 877–86]
DRD2 and DAT1
Energy intake was greater for individuals high in food
reinforcement and greatest in those high in food reinforcement
with the TaqI A1 allele
Healthy Japanese men, n=295 [J
Epidemiol 15 (2005) 203–10]
ADRB3 Trp64Arg
High energy intake interacts with the polymorphism and leads
to a significant increase in risk of obesity. The Trp64Arg
polymorphism of ADRB3 warrants consideration, along with
other polymorphisms involved in the development of obesity, for
tailor-made prevention of obesity
85 healthy Japanese men [Metabolism
56 (2007) 925–30]
Asp358Ala (T/G)
polymorphism in the
interleukin 6 receptor
(IL6R) gene
Dietary energy intake modifies the association between gene
and waist circumference
Selected obese women – diet responsive
(n=74) and diet-resistant (n=67)
[Obesity (Silver Spring) 15 (2007)
1068–75]
Two PPARgamma
SNPs, Pro(12)Ala and
C1431T, and eight
polymorphisms across
the ACSL5 gene
The PPARgamma Pro(12)Ala single nucleotide polymorphism
was associated with diet resistance (odds ratio = 3.48, 95%
confidence interval = 1.41 to 8.56, p = 0.03) after the first 6
weeks of a 900-kcal formula diet (low calorie)
67 volunteers in the 10 week
low-energy diet program, followed by a
1-year weight-loss maintenance [Br J
Nutr 96 (2006) 965–72]
–174G>C from IL-6
and PPAR-gamma2
Pro12Ala variants
The present study demonstrates that the C allele of the
–174G>C polymorphism gives protection against regain of
weight lost. Moreover, the presence of the Ala allele of the
PPARgamma-2 together with the C allele strengthens this
protection
351 French-Canadians, 40 overweight
subjects and 4 controls [J Mol Med 85
(2007) 129–37]
CPT1
Indices of obesity might be modulated by an interaction
between CPT1 variants and fat intake
549 adult obese women recruited from
eight European centres [Eur J Nutr 45
(2006) 454–62]
42 polymorphisms in 26
candidate genes
The test of interaction between fibre intake and the –514 C >
T polymorphism of the hepatic lipase gene (LIPC) was
significant; the –11377G > C polymorphism of the adiponectin
gene (ADIPOQ) and the –681 C > G polymorphism of the
PPARG3 gene might interact with the percentage of energy
derived from fat in the diet, for the development of obesity
60 obese women exposed to short-term
and long-term hypocaloric diets,
varying in macronutrients [Nutr Hosp
21 (2006) 317–31]
PPARgamma2 and
beta2 – adrenergic
receptor genes
Intake of dietary fats and saturated fatty acids should be
controlled in Pro12Pro/Gln27Gln and Pro12Pro/Gln27Glu, and
complex CHO and MUFA in Pro12Pro/Glu27Glu. In
Pro12Ala/Gln27Glu, AGPI intake can result in greater body
weight loss
14-week calorie restriction diet in 95
middle-aged, Japanese women (BMI
>/=25 kg/m2) [Obesity (Silver Spring)
17 (2009) 1924–31]
rs2959272, rs1386835,
rs709158, rs1175540,
rs1175544, and
rs1797912 in the
PPARG gene
Body weight decreased significantly (–7.7+/–3.1 kg;
–11.3+/–4.4%). All six SNPs were found to be associated with
the weight reduction, with rs1175544 having the strongest
association
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Non-diabetic/overweight-obese Koreans
(n=177) [J Int Obes (Lond) 30 (2006)
1601–8]
6209T>C, 10076C>G,
10171A>T, 11482G>A,
13042A>G, 13048C>T
and 14995A>T in
perilipin (PLIN) – a
class of protein-coating
lipid droplets in
adipocytes
Subjects with nCA/nCA haplotypes at SNPs
10076C>G/10171A>T showed greater reduction in FFA levels
than those with CA/CA haplotype after a 12-week calorie
restriction (–300kcal/day) program
606 hyperlipaemic and overweight men
[Clin Genet 68 (2005) 152–4]
Several SNPs (wildtype
and carriers of the
–1131T>C
polymorphism) in the
Apolipoprotein A5 gene
Reduction of BMI was significantly higher in C allele carriers
after a short-term dietary fat restriction
150 obese patients at baseline and 48
patients who completed the dietary
follow-up; randomised trial with 1-year
low energy diet [J Clin Endocrinol
Metab 90 (2005) 5121–6]
Minor A-allele at the
PLIN 11482G>A
polymorphism
PLIN11482A carriers were resistant to weight loss
224 overweight-obese subjects with
coronary artery disease (CAD) or
metabolic syndrome [Int J Obes Relat
Metab Disord 28 (2004) 434–41]
Participants subdivided
into 4 categories:
(TT-CC, n=73);
(TT-CT/TT, n=90);
(TA/AA-CC, n=29);
(TA/AA-CT/TT, n=32)
according to status on
beta3-AR and UCP3
After a –300 kcal/day mild weight reduction program for 12
weeks, the beneficial effects on body fat distribution and
glycemic control were greatest in the 'wild-type' group and
smallest in 'both variants' group. In addition, these effects were
less beneficial in carriers with beta3-AR gene variant than with
UCP3 gene promoter variant
EPIC-Heidelberg: 154 subjects with a
body mass index > 35 kg/m(2) and 154
age- and sex-matched normal-weight
controls; dietary fatty acid intake
assessed by food frequency
questionnaire [Eur J Nutr 41 (2002)
210–21]
PPARA, PPARG2,
UCP1, UCP2, UCP3,
BAR-2, APM1, leptin,
SORBS1, HSL, and
TNFA
Gene-diet interactions suggest that the allelic variants of
candidate genes (leptin, TNFA, PPARG2) might strongly affect
diet-related obesity risk
61 women with the APOE 2/3 and
APOE 3/3 genotype (APOE4-) and 18
women with the APOE 3/4 genotype
(APOE4+) [Metabolism 51 (2002)
853–8]
Apolipoprotein E
(APOE)
It may be prudent to genotype older women before initiating
low-fat diet therapy, as those with the APOE4 allele benefit the
most, while the lipid profile could worsen in women without the
APOE4 allele after a low-fat, low-cholesterol diet over 10 weeks
170 Caucasian participants [Arch Med
Res 40 (2009) 306–10]
Lys109Arg in the leptin
receptor gene (LEPR)
The Arg allele carriers of the Lys109Arg LEPR gene
polymorphism were associated with an increased
proinflammatory state and stress condition at baseline. These
obesity-related markers were importantly decreased after an
8-week energy-restricted (hypocaloric) diet (–30% E) diet
Low-fat vegan diet or a diet for 74
weeks among 93 adults with type 2
diabetes [Nutrition 25 (2009) 58–65]
A1A1 and A1A2 in the
D2 dopamine receptor
Among whites in the vegan group, A1(+) individuals reduced
fat intake (P = 0.04) and A1c (P = 0.01) significantly less than
did A1(–) individuals
131 obese individuals (body mass index
>30) [Horm Metab Res 41 (2009) 62–6]
–55CT polymorphism in
the UCP3 gene
Carriers of the T variant experienced decreases in BMI, weight,
and fat mass on two different hypocaloric diets, without
statistical changes in biochemical parameters
363 subjects with impaired fasting
glucose (IFG) or newly diagnosed type
2 diabetes followed a dietary
intervention and regular walking for 12
weeks without any medication
[Diabetes Care 32 (2009) 552–8]
ADIPOQ
ADIPOQ genetic variants can affect circulating adiponectin
levels and insulin resistance indexes in subjects with IFG or
newly diagnosed type 2 diabetes in response to dietary
intervention
Mixed interventions
507 overweight individuals randomised
to intensified diet and physical activity
group or a conventional care control
group [BMC Med Genet 10 (2009) 94]
rs659366, rs653529,
rs15763, and
rs1726745; rs659366-G,
rs653529-A, rs15763-G
and rs1726745-A in the
UCP2 and UCP3
Genetic variation in the UCP2-UCP3 gene cluster may act as a
modifier increasing serum lipid levels and indices of abdominal
obesity, and may thereby also contribute to the metabolic
aberrations observed in obesity and type 2 diabetes
tance. In the initial report of the RIVAGE study, some
SNPs showed interactions with a metabolic response to
diet (through ApoE and LDL-cholesterol and triacylgly-
cerols, apoA-IV and LDL cholesterol, MTP and LDL-cho-
lesterol, intestinal fatty acid-binding protein, and triacyl-
glycerols).
Ethnic specific and region specific responses, possibly
related to diet, were shown to be mediated by several
SNPs in the human integrin beta 2 subunit (ITGB2) gene,
the diacylglycerol acyltransferase (DGAT) gene, as well
as thrifty genes FABP”, MTP, CAL10, beta 3AR, apo-E,
UCP2, UCP3-p, PPARgama2, and LEPR.
None of the abstracts reported on a link between any
SNPs and smoking, whereas psychological stress was
only mentioned in one article, where it was reported to
have been reduced following an 8-week hypocaloric diet.
Studies identified through HuGE Navigator fell in
one of three categories, where SNPs were linked with in-
creased body weight and either physical activity, diet
characteristics, or some type of a mixed intervention aim-
ed at reducing body weight, which invariably combined
modification of both physical activity and dietary habits.
Physical activity extended an exacerbated protective
effect on body weight or metabolic events when coupled
with several polymorphisms in the BAR-2, FTO, MC4R,
LIPE, GNB3, UCP3, and the PPARG gene. An exception
was the ADRA2B gene where, in a Chinese population,
the D allele conferred a favourable anthropometric and
metabolic profile, especially when combined with lower
levels of physical activity.
Some studies found gene-obesity-diet interactions. Car-
riers of GNB3 C825T seem to feel mental discomfort
when fasting, which may explain their increased suscep-
tibility towards increased body weight. The 11391/A allele
in the adiponectin gene may protect from weight regain
after a low-calorie dietary intervention. A low-calorie
diet also seems to be a good choice for carriers of CB1,
NPY, 420C>G polymorphisms in the resistin gene: allele
carriers had a better response to the dietary regimen in
terms of weight loss and metabolic changes, when com-
pared to wild type participants.
In one study, a minor allele in the rs894160 on the
PLIN gene was associated with additional weight gain,
but only combined with low intake of carbohydrates;
when coupled with higher intake of complex carbohy-
drates, the allele seems to have played a protective role
against obesity. Another study found that both carriers
of wild type and mutant alleles on the Lys656Asn locus
in the LEPR gene lost weight in response to a low-fat, as
well as a low-carbohydrate diet. However, only wild type
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120 obese Japanese women and 146
healthy age-matched controls; diet and
exercise therapy for 6 months
[Metabolism 55 (2006) 819–24]
Angiotensinogen (AGT)
Met235Thr
polymorphism (M235T)
The T/T genotype of the AGT M235T gene polymorphism was
positively related to visceral obesity and hyperinsulinemia
67 obese (body mass index >30)
nondiabetic outpatients [Arch Med Res
37 (2006) 854–9]
Lys656Asn
polymorphism in the
leptin receptor gene
Patients with Asn656 allele of LEPR gene have a different
response to a lifestyle modification program than wild-type
patients, and Lys656Lys patients have a significant decrease in
weight, BMI, fat mass, waist circumference, systolic blood
pressure and leptin levels
69 obese (body mass index > 30)
nondiabetic outpatients [Ann Nutr
Metab 50 (2006) 354–60]
Thr54 polymorphism in
the FABP2 gene
Carriers of the Thr54 allele have a different response to a
lifestyle modification (Mediterranean hypocaloric diet and
exercise) than wild-type obese subjects, with a significant
decrease of systolic blood pressure and glucose levels in Thr54
carriers and a significant decrease in fat mass, low-density
lipoprotein cholesterol, and leptin in wild-type patients
76 perimenopausal women with no
clinical symptoms; 3-month
behavioural intervention study using a
combination of diet and exercise
programs [Int J Obes Relat Metab
Disord 27 (2003) 1028–36]
Trp64Arg mutation in
the beta(3)-adrenergic
receptor (beta(3)AR)
gene
The mutation is associated with difficulty in losing weight
through behavioural intervention, although it is not related to
obesity-related phenotypes and resting energy expenditure
before the intervention
69 obese non diabetic outpatients [Med
Clin (Barc) 129 (2007) 401–4]
G308A variant in the
tumor necrosis factor
alpha (TNF-alpha) gene
Carries of G308G variant of TNF-alpha gene have a better
metabolic response (to a 3-month of lifestyle modification
program that included a hypocaloric diet 1,520 kcal) than A308
obeses
Randomised controlled trial of 3,548
high-risk individuals from 27
participating centres throughout the
USA [Diabetologia 51 (2008) 2214–23]
rs9939609 in the FTO
gene and rs7566605 in
the INSIG2 gene
Within the DPP study population, common variants in FTO
and INSIG2 are nominally associated with quantitative
measures of obesity, directly and possibly by interacting with
metformin or lifestyle intervention
151 subjects participating in a lifestyle
intervention program to prevent
diabetes [Exp Clin Endocrinol Diabetes
117 (2009) 194–7]
rs8050136 in FTO
Increased body weight in carriers of the risk allele of FTO SNP
rs8050136 is a consequence of increased food intake, but not of
impaired energy expenditure
carriers had lower leptin concentrations, which was seen
with both tested diets.
A hypocaloric diet seems to work well for people with
the -55CT polymorphism of the UCP3 gene, whereas
having the PPARgamma Pro(12)Ala SNP may confer re-
sistance to a low-calorie diet. On the contrary, the C allele
of the PPARgamma-2-174G>C SNP seems to protect
against regain of lost weight, and this effect is further
strengthened by the presence of the Ala allele of the
PPARgamma-2. Another study found that some CPT1
variants may modify body weight response to fat intake.
Several genotype-by-nutrient interactions were con-
firmed in a study of 549 obese European women. Although
the study tested 42 polymorphisms in 26 candidate ge-
nes, the only tests that yielded statistical significance
were for the interaction between fiber intake and the
–514 C > T polymorphism of the LIPC gene, as well as
those for fat intake and –11377G > C polymorphism of
the ADIPOQ gene and the –681 C > G polymorphism of
the PPARG3 gene.
Carriers of the minor allele PLIN11482A showed re-
sistance to weight loss after a 1-year low-energy dietary
program. Women with APOE4 allele benefit the most from
a low-fat, low-cholesterol diet, whereas the lipid profile
could worsen in women without the APOE4 allele.
Finally, response to complex interventions that inclu-
de advice on both diet and physical activity may be ham-
pered or facilitated by various SNPs in the UCP2, UCP3,
AGT, LEPR, FABP2, beta(3)AR, TNF-alpha, FTO, and
INSIG2 genes.
Discussion
We have identified in the literature a number of SNPs
that may be associated with increased risk for over-
weight or obesity and also with behavioural risk factors
for these traits. With the advent of personalised health
care, results of SNP genotyping are likely to start guid-
ing personalised prevention of complex diseases in the
near future.
Personalised prevention of obesity may develop two-
fold: as behaviourally based or pharmacogenomic approa-
ches. Based on our findings, it is imaginable that, for ex-
ample, carriers of rs1477196 and rs1861868 in the FTO
gene would need to be advised to make sure they kept
physically active above levels recommended for the general
population, as this may protect them from excess weight.
Carriers of P129T polymorphism in fatty acid amide hy-
drolase and carriers of APOA5-1131T>C polymorphism
may need to be advised to opt for low-fat diets, whereas
low-energy diets may prove a better choice for carriers of
ht1 on the UCP-3 gene, carriers of A-3826G, A-1766G, and
G+1068A on the UCP-1 gene, and carriers of 276G>T at
the ADIPOQ gene. APOA5-1131T>C polymorphism is of
particular interest and preventive potential, due to its
high prevalence of 13% in the studied population.
These and most probably other SNPs hold promise for
future design of personalised behaviourally based inter-
ventions for preventing obesity. However, we are still in
the discovery phase of genomics obesity research15. Most
of the gene-environment-behaviour interactions explor-
ed in this paper have only been tested in a single study.
Moreover, studies are often poorly described and lack
methodological detail necessary for critical appraisal;
samples are often small, include healthy volunteers, or
no information is given on the selection process; analysis
frequently fails to account for multiple testing, and only
some studies report the proportion of variance explained
by any given gene variant. Indeed, more than half of the
obesity related genes in the HuGE Navigator’s Pheno-
pedia have only been implicated in a single study thus
far. It is likely that many of these associations may be re-
jected in future replication studies.
We believe now is the time to help obesity genomics
on the long road towards effective clinical and public
health interventions, not least by developing reporting
standards – which are lacking for this field of research.
This gap has been somewhat filled while our paper was
under review16. Some of the included studies reported
sufficient information on markers (including i.e. rs code
for SNP markers, which are widely accepted unique SNP
identifiers), while some reported SNP or other descrip-
tions in a non-standardised way. Results were not always
clearly stated, especially in the articles covering gene-
-obesity-diet interactions.
These issues made us consider and investigate the
feasibility of using some of the existing standards. Al-
though a number of relevant attempts have been made,
including the GO ontology and several applications that
use the XML language, we could not identify any applica-
tions that could fit the available data from the included
studies, which are commonly reporting a simple associa-
tion of a genetic marker with some phenotypic trait or a
disease.
Given the already large number of studies reporting
on gene-obesity-behaviour interactions, an enormous po-
tential for similar future work, as well as the relevance of
this line of research for population health, it would seem
prudent to consider developing a specific reporting stan-
dard for these studies. At the very least, following the re-
porting practice developed for other study designs (e.g.
CONSORT for clinical trials), we would argue in favour
of stating the study design as part of the title, as well as
introducing a structured abstract that would include the
information on a unique SNP identifier (rs code), effect
allele, physical SNP location (usually defined as the
number of base pairs from the chromosome start), chro-
mosome, gene name, analysed trait, information on pos-
sible effect modifiers (i.e., adjustment for age and sex,
other confounders, multivariate methods), proportion of
variance, and other information. The application and use
of such structured reporting format would likely enable
creation of more informative, perhaps even entirely com-
puter-generated summary reports. Establishing a vocab-
ulary consensus in describing elements of study and
data, for the purpose of annotation and integration,
would also be a valuable contribution to the field.
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As we contemplate what effects genetic testing, once
widely available, might have on people’s motivation to
lose weight or the public’s readiness to accept the new re-
alities or, indeed, what new types of obesity might soon
become definable in the disease categorisation of the
genomic era, some improvement in the scientific commu-
nication to help us get there faster seems advisable. This
seems in tune with views of others previously expressed
in this journal17.
Strengths and limitations
We have conducted a comprehensive search across
multiple databases and present in one place current state
of the evidence relevant to the development of future
behaviourally based obesity prevention strategies. How-
ever, we did not hand search the references in the in-
cluded articles and it is possible that some published
studies escaped our search strategy. Furthermore, we did
not perform a formal assessment of the quality of the in-
cluded studies, as we felt this was beyond the scope of the
paper. Finally, we have not attempted to synthesise the
findings at this stage, due to the heterogeneity of the in-
cluded studies.
Conclusions
Personalisation of behaviourally based preventive ap-
proaches against obesity seems feasible in the near fu-
ture. Automation of search algorithms, as well as devel-
opment of more efficient tools for knowledge synthesis of
genomic research into gene-obesity-behaviour interac-
tions might facilitate the advent of widely available per-
sonalised prevention strategies. As a small step forward,
we propose that structured standards of reporting spe-
cific to the field be developed as soon as possible, so as
not to unnecessarily delay translation of these burgeon-
ing findings into clinical and public health practice. In
addition, our future efforts shall concentrate on develop-
ing a research repository dedicated to the use of public
health genomics for obesity control.
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UTIRANJE PUTA ZA PERSONALIZIRANU PONA[AJNU PREVENCIJU PRETILOSTI:
SUSTAVNA PRETRAGA LITERATURE
S A @ E T A K
Cilj ovog rada bio je identificirati polimorfizme jednog nukleotida (SNP, od engl. single nucleotide polymorphism)
koji bi mogli odrediti interindividualne razlike u odgovoru, u smislu promjene tjelesne te`ine, na pojedine pona{ajne
~imbenike rizika za prekomjernu debljinu ili pretilost, stoga otvaraju}i mogu}nosti za personalizirane pona{ajne pre-
ventivne intervencije. U bibliografskim bazama, bez jezi~nih restrikcija, identificirali smo radove koji su izvje{tavali o
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povezanosti pojedinih SNP-ova s prekomjernom debljinom ili pretilo{}u kao i s pona{ajnim rizi~nim ~imbenicima za
razvoj ovih zna~ajki. Identificirali smo 64 genske varijante koje bi mogle biti uklju~ene u interakcije gen-pretilost-
-pona{anje. Temeljem ovih rezultata mogu}e je zamisliti razvoj personaliziranog savjetovanja o promjeni `ivotnih navika,
s ciljem smanjena tjelesne te`ine, me|utim genomika pretilosti jo{ je u ranoj translacijskoj fazi; potrebna je replikacija
rezultata u brojnim budu}im istra`ivanjima prije no {to ovi u velikoj mjeri pionirski rezultati unaprijede klini~ku i
javnozdravstvenu praksu. U kvaliteti istra`ivanja kao i izvje{tavanja o njima ima mnogo prostora za pobolj{anja. Za-
klju~ujemo da je personalizacija pona{ajnih preventivnih intervencija protiv pretilosti izvediva no automatizacija pre-
tra`iva~kih algoritama i razvoj u~inkovitijih metoda sinteze znanja generiranih u genomskim istra`ivanjima mogli bi
ubrzati translaciju prema {irokoj dostupnosti personaliziranih preventivnih pristupa. Na{a }e budu}a nastojanja stoga
uklju~ivati razvoj takvih metoda i oru|a, kao i razvoj repozitorija istra`ivanja posve}enog uporabi javnozdravstvene
genomike u kontroli pretilosti.
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